SOLID BIOSCIENCES INC.
Last · —$5.465-0.355 (-6.10%)live · yahoo · 36m ago
Vol 2.38M ≈ 13.00M
MA10MA20MA50
Market cap$585.99M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameSOLID BIOSCIENCES INC.
HQUnited States (US)
ListingUS SLDB
ISINUS83422E2046
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC2836
CurrencyUSD
Entity registrysec:0001707502
CIK0001707502
Websitewww.solidbio.com
Employees121
AddressSolid Biosciences, Inc. 500 Rutherford Avenue 02129, Charlestown
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-19
From latest 10-K · 2026-03-19
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.4 years
- Accumulated Deficit High — Accumulated deficit / equity 532%
Upcoming earnings
MON.2NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.41
Est. revenue
0
Press & signals
- GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Documents
FormReporting forFiledFlags
Showing 5 of 126 filings